- Little Green Pharma (LGP) has received a $2.5 million purchase order from DEMECAN for 21,300 units of its medicinal cannabis flower medicine
- This is the fourth order DEMECAN has placed, following 500, 9000 and 17,000 units for delivery in CYQ1, CYQ2 and CYQ3, respectively
- This new order brings DEMECAN's total orders to 47,800 units for a total cost of $5.7 million in CY21 alone
- To capitalise on the growing demand, Little Green Pharma has brought its existing cultivation facilities to full capacity
Read the Full Article on The Market Herald here
Little Green Pharma (ASX:LGP) receives $2.5M purchase order from DEMECAN
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.73M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 13.0¢ | $1.311K | 10.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 893792 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 268237 | 7 |
View Market Depth
| Last trade - 09.59am 02/09/2025 (20 minute delay) ? |
| LGP (ASX) Chart |